Gold Nanorod-Based Nanohybrids for Combinatorial Therapeutics

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Multifunctional nanocarriers are crucial for advanced cancer therapeutics.
• Combining hyperthermia and chemotherapy offers synergistic treatment potential.
• Gold nanorods possess unique photothermal properties for targeted therapy.

Purpose of the Study:

• To develop and characterize multifunctional nanocarriers for combined photothermal therapy and chemotherapy.
• To investigate the drug loading efficiency and release mechanisms.
• To evaluate the synergistic cytotoxic effects on cancer cells.

Main Methods:

• Layer-by-layer assembly of poly(sodium-4-styrenesulfonate)/doxorubicin/poly-l-lysine hydrobromide/hyaluronic acid-coated gold nanorods.
• Drug loading efficiency determination via electrostatic interactions.
• In vitro cytotoxicity assays on HeLa and MDA-MB-231 cancer cells.
• Analysis of cell death mechanisms (necrosis and apoptosis).

Main Results:

• High doxorubicin loading efficiencies achieved (up to 78.3%).
• Enhanced nanohybrid internalization due to hyaluronic acid targeting CD44 receptors.
• Synergistic cytotoxic effects observed in vitro.
• Distinct cell death pathways induced by photothermal therapy (necrosis) and doxorubicin (apoptosis).

Conclusions:

• The developed nanohybrid system is a versatile platform for targeted thermo-chemotherapy.
• Controlled drug release achieved through enzymatic degradation and near-infrared laser irradiation.
• This approach offers a novel, controllable, and effective anticancer strategy.